BRAIN Biotech AG

Declaration of Voting Results & Voting Rights Announcements • Oct 20, 2025

News Details

Voting rights Announcements | 20 October 2025 15:38

Universal-Investment-Gesellschaft mit beschränkter Haftung, Frankfurt am Main, Germany

BRAIN Biotech AG

BRAIN Biotech AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

20.10.2025 / 15:38 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by EQS News – a service of EQS Group.

The issuer is solely responsible for the content of this announcement.

---

Notification of Major Holdings

1. Details of issuer

Name:	BRAIN Biotech AG
Street:	Darmstädter Straße 34-36
Postal code:	64673
City:	Zwingenberg Germany
Legal Entity Identifier (LEI):	391200JKPVHLD6JLZ107

2. Reason for notification

X	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
	Change of breakdown of voting rights
	Other reason:

3. Details of person subject to the notification obligationLegal entity: Universal-Investment-Gesellschaft mit beschränkter Haftung

City of registered office, country: Frankfurt am Main, Germany

4. Names of shareholder(s)

holding directly 3% or more voting rights, if different from 3.

5. Date on which threshold was crossed or reached:15 Oct 2025

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	Total of both in % (7.a. + 7.b.)	Total number of voting rights pursuant to Sec. 41 WpHG
New	2.99 %	0.00 %	2.99 %	21847495
Previous notification	4.99 %	0.00 %	4.99 %	/

7. Details on total positions

a. Voting rights attached to shares (Sec. 33, 34 WpHG)

ISIN	Absolute		In %
	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)	Direct (Sec. 33 WpHG)	Indirect (Sec. 34 WpHG)
DE0005203947	0	652894	0.00 %	2.99 %
Total	652894		2.99 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
			0	0.00 %
		Total	0	0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
				0	0.00 %
			Total	0	0.00 %

8. Information in relation to the person subject to the notification obligation

	Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least 3% or more)	% of voting rights through instruments (if at least 5% or more)	Total of both (if at least 5% or more)
-Universal-Investment-Gesellschaft mit beschränkter Haftung	%	%	%
-Universal-Investment-Luxembourg S.A.	%	%	%

9. In case of proxy voting according to Sec. 34 para. 3 WpHG

(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:

Holding total positions after general meeting (6.) after annual general meeting:

Proportion of voting rights	Proportion of instruments	Total of both
%	%	%

10. Other explanatory remarks:

Date

17 Oct 2025

---

20.10.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

View original content: EQS News

---

Language:	English
Company:	BRAIN Biotech AG
	Darmstädter Straße 34-36
	64673 Zwingenberg
	Germany
Internet:	www.brain-biotech.com

End of News	EQS News Service

---

2215672  20.10.2025 CET/CEST